Clinical Research Enrollment Grants (CRE)
The CRE Request for Applications (RFA) for the 2017 - 2019 granting cycle (April 2017 - March 2019) is now available! The deadline to apply will be November 4, 2016 and award notification will be made at the end of February 2017. You must submit a Letter of Intent (LOI) prior to applying. The deadline for the LOI is September 23, 2016.
Women, especially racial and ethnic minorities, are not adequately represented in cancer research efforts. Multiple barriers — cultural, linguistic, financial, and systematic — hinder their participation in clinical research, particularly in clinical trials. Through Clinical Research Enrollment Grants, Komen Greater NYC seeks to fund projects that employ effective strategies to overcome these barrier to enrollment and retention in breast cancer clinical research.
To apply for a Komen Greater NYC Clinical Research Enrollment Grant, your organization must be:
- A federally tax exempt entity – non-profit organization, government agency, educational institution or Native American tribe.
- Conducting National Cancer Institute (NCI) or Department of Defense (DOD)-approved breast cancer clinical research, including studies sponsored by National Clinical Trials Network. The proposed enrollment program may refer patients to non-NCI or DOD approved research studies supported by the applicant institution as long as NCI or DOD research is being conducted as well.
- Located in Komen Greater NYC service area – the five boroughs of New York City, Long Island, Westchester and Rockland Counties.
The funding period is 2 years, based on the Komen Greater NYC fiscal year – April 1st through March 31st. Programs applying for the CRE grant may request up to $150,000 over this two-year period. Organizations that have previously received Komen Greater NYC funding are welcome to aplly for additional funding.
View How To Apply.